Frontiers in Oncology | Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Original Research

Accepted on 26 Sep 2025

TACE Combined with Regorafenib With or Without Anti-PD-1 Therapy for Advanced HCC After Targeted Therapy Failure: A Multicenter Real-World Study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yan Li
Hang Yuan
Quan-Jun Yao
Xiang Geng
Fei Xu
Weijun Fan
Gang Wu
Guang-Shao Cao
Ho-Young Song
Hong-Tao Hu

Frontiers in Oncology

doi 10.3389/fonc.2025.1652319

211 views

Case Report

Accepted on 26 Sep 2025

Giant cystic solid aggressive fibromatosis of the pancreas: clinical and pathologic features

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Runlin Feng
Tao Zhang
Lijuan Feng
Yanping Tao
Jiaping Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1634715

153 views

Original Research

Published on 26 Sep 2025

Efficacy and safety of antiangiogenic agents combined with HIFU in the treatment of advanced liver cancer

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Rong Wu
Qiuling Shi
Dongbiao Liao
Yao Liao
Feng Sun
Yu He
Peiyang Mao
Lingli Fan
Yuxi Bai
Gang Feng

Frontiers in Oncology

doi 10.3389/fonc.2025.1652434

544 views

Case Report

Accepted on 24 Sep 2025

Case Report: Efficacy of Preoperative Conversion Therapy with Lenvatinib, Toripalimab, and Hepatic Arterial Infusion Chemotherapy in an Advanced Hepatocellular Carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jing Mao
Hengzhi Zhang
Xingxia Yang
Yanjun Yao
Xu Sun
Qiang Yan

Frontiers in Oncology

doi 10.3389/fonc.2025.1627281

370 views

Original Research

Accepted on 24 Sep 2025

Global burden and cross-country inequalities of gallbladder and biliary tract cancer in adults aged 45 years and older from 1990 to 2021: Population-based study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Simeng Lei
Yangkai Fu
Bo Zhang
Hanwen Yang
Yang Hu
Zhili Ji

Frontiers in Oncology

doi 10.3389/fonc.2025.1676636

273 views

Case Report

Accepted on 22 Sep 2025

Case Report: First case of percutaneous transhepatic cholangioscopy guided triple bridge drainage between multiple bile ducts for malignant hilar biliary obstruction

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Gang Tang
Jie Zhang
Rui Chen
Jingyi Zhang
Rongxing Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1620937

485 views

Case Report

Accepted on 22 Sep 2025

Undifferentiated high-grade sarcoma with UES-like features in the retroperitoneum: a case report with TP53 p.R306 mutation

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yinan Zhu
Mingfang Sun
Ziyue Wang
Xuyong Lin

Frontiers in Oncology

doi 10.3389/fonc.2025.1672264

399 views

Review

Accepted on 19 Sep 2025

Immunohistochemistry in intrahepatic cholangiocarcinoma: histological subtyping and drug selection

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Han Wang
Miao-Xia He
Wen-Ming Cong
Hui Dong

Frontiers in Oncology

doi 10.3389/fonc.2025.1653534

714 views

Original Research

Published on 19 Sep 2025

The combination treatment of oncolytic adenovirus H101 with transcatheter arterial embolization sequential thermal ablation for hepatocellular carcinoma: a retrospective study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Changyou Jing
Tong Zhu
Yonghong Zhang
Jianjun Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1623877

794 views

Review

Published on 19 Sep 2025

Decoding the microbial-local immune dialogue in liver cancer: from ecological drivers to precision therapeutics

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yichi Xu
Bo Wen
Nan Gao
Shu Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1629479

659 views

Case Report

Published on 18 Sep 2025

Curative response to combined targeted-immunotherapy for post-hepatectomy lymph node metastasis in sarcomatoid hepatocellular carcinoma: case report and literature review

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Pan Liu
Song Zhang
Xiao-Ming Xin
Min Jing
Lie-Dong Wen
Xin Xiang
Shun-Hai Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1591419

1,425 views

Original Research

Accepted on 17 Sep 2025

Time to Recurrence and BCLC Stage at Recurrence as Critical Variables in Guiding Treatment Decisions for Early-Recurrent Hepatocellular Carcinoma after Liver Resection

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jian-Xi Zhang
Luo-Bin Guo
Chong-Shi Zeng
Qi-Zhen Huang
Zi-Sen Lai
Meng-Meng Wu
Qingjing Chen
Yong-Ping Lai
Xin-Feng Qiu
Bing Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1672696

375 views

Original Research

Published on 17 Sep 2025

TFF2, a novel serum diagnostic biomarker for early pancreatic cancer

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xiangyu Wu
Xiuhong Huang

Frontiers in Oncology

doi 10.3389/fonc.2025.1633069

594 views

Original Research

Published on 17 Sep 2025

Exploring 2D and 3D radiomic models for predicting microvascular invasion in hepatocellular carcinoma: a novel perspective on tumor heterogeneity

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Zexin Yin
Meilong Wu
Youyao Li
Zhike Li
Shiyun Bao
Liping Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1590655

514 views

Case Report

Published on 17 Sep 2025

Molecular profiling of circulating tumor cells guides effective EGFR inhibitor treatment in advanced hepatocellular carcinoma: a case report

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Wei Chiu
San-Chi Chen
Yee Chao
Jan‐Mou Lee

Frontiers in Oncology

doi 10.3389/fonc.2025.1608604

643 views

Original Research

Published on 16 Sep 2025

Identification of amino acid metabolism-related gene Leucyl-tRNA synthetase 1 (LARS1) as a potential prognostic and therapeutic target in hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Qiyu Shi
Yirong Chi
Ziyi Peng
Chao Li
Jingwen Zhao
Jie Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1675018

664 views